HighTower Advisors’s Organon & Co OGN Stock Holding History
Bought
Maintained
Sold
Other funds holding OGN
PCM
AA
HighTower Advisors's OGN Position: Q2 2026 in Review
HighTower Advisors reduced its Organon & Co (OGN) stake by 5% in Q2 2026, selling an estimated $29.5K and leaving 46,549 shares worth $630K. The position accounts for ﹤0.01% of the portfolio, ranked #2565.
HighTower Advisors first reported a position in OGN in Q2 2021 and has held it in 21 quarters since. The position peaked at $3.63M in Q3 2021. 633 funds tracked by Wall St. Rank hold OGN as of Q2 2026.
- HighTower Advisors held 46,549 shares of Organon & Co worth $630K as of Q2 2026.
- HighTower Advisors sold 2,470 Organon & Co shares in Q2 2026, an estimated $29.5K.
- Organon & Co made up ﹤0.01% of HighTower Advisors's portfolio in Q2 2026, its #2565 holding.
- HighTower Advisors first reported a position in Organon & Co in Q2 2021 and has held it in 21 quarters since.
- HighTower Advisors's Organon & Co position peaked at $3.63M in Q3 2021.
- 633 funds tracked by Wall St. Rank held Organon & Co as of Q2 2026.
Based on HighTower Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.